Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia
Clinical Lymphoma Myeloma and Leukemia(2019)
Abstract
Acute Lymphoblastic Leukemia (ALL) is an aggressive malignancy, highly sensitive to induction chemotherapy with high rates of complete remissions. Long-term survival is less than 35% as a major result of the high incidence of relapses. Allogeneic stem cell haematopoietic stem cell transplantation (AHSCT) represents the therapy with the greatest antileukemic potential and probability of survival.
MoreTranslated text
Key words
acute lymphoblastic leukemia,ALL,allogeneic transplantation,related donors,stem cell transplantation,unrelated donors
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined